CARDIOVASCULAR JOURNAL OF AFRICA • Volume 33, No 3, May/June 2022 144 AFRICA 24. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42(2): 377–381. 25. Fox KAA, Goodman SG, Klein W, et al. Management of acute coronary syndromes. Variations in practice and outcome: Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002; 23(15): 1177–1189. 26. Budaj A, Brieger D, Steg PG, et al. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2003; 146(6): 999–1006. 27. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002; 90(4): 358–363. 28. Mandelzweig L, Battler A, Boyko V, et al. The second Euro heart survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean basin in 2004. Eur Heart J 2006; 27(19): 2285–2293. 29. Geyser M, Smith S. Chest pain prevalence, causes, and disposition in the emergency department of a regional hospital in Pretoria. Afr J Prim Health Care Fam Med 2016; 8(1): 1–5. 30. Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome. J Am Med Assoc 2014; 291(22): 2727–2733. 31. Kennelly BM. Aetiology and risk factors in young patients with recent acute myocardial infarction. S Afr Med J 1982; 61(14): 503–507. 32. Chetty R, Ross A. Chart review of acute myocardial infarction at a district hospital in KwaZulu-Natal, South Africa. Afr J Prim Health Care Fam Med 2016; 8(1): 1012. 33. Gersh BJ, Granger CB. Progress in regional systems of care for STEMI in low- and middle- income countries. AsiaIntervention 2021; 7: 11–14. 34. Alexander T, Mullasari AS, Joseph G, et al. A system of care for patients with ST-segment elevation myocardial infarction in India: the Tamil Nadu–ST-Segment Elevation Myocardial Infarction program. J Am Med Assoc Cardiol 2017; 2(5): 498–505. 35. Candiello A, Alexander T, Delport R, et al. How to set up regional STEMI networks: providing best possible STEMI care. EuroIntervention 2021: EIJ-D-21-00694. Epub ahead of print. 36. Mabuza LH, Mntla PS. Generalist practitioners’ self-rating and competence in electrocardiogram interpretation in South Africa. Afr J Prim Health Care Fam Med 2020; 12(1): 1–7. 37. Cook DA, Oh SY, Pusic MV. Accuracy of physicians’ electrocardiogram interpretations: A systematic review and meta-analysis. J Am Med Assoc Intern Med 2020; 180(11): 1461–1471. AI arrhythmia predictor has potential to transform clinical decision-making A new artificial intelligence-based approach can predict, significantly more accurately than a doctor, if and when a patient could die of cardiac arrest. The technology, ‘has the potential to transform clinical decision-making’, according to the study, published in Nature Cardiovascular Research. ‘Sudden cardiac death caused by arrhythmia accounts for as many as 20% of all deaths worldwide and we know little about why it’s happening or how to tell who’s at risk,’ said senior author Natalia Trayanova, the Murray B Sachs professor of Biomedical Engineering and Medicine at Johns Hopkins University, who led the study. ‘There are patients who may be at low risk of sudden cardiac death getting defibrillators they might not need and then there are high-risk patients who aren’t getting the treatment they need and could die in the prime of their life. What our algorithm can do is determine who is at risk for cardiac death and when it will occur, allowing doctors to decide exactly what needs to be done.’ The team is the first to use neural networks to build a personalised survival assessment for each patient with heart disease. These risk measures provide, with high accuracy, the chance for a sudden cardiac death over 10 years, and when it’s most likely to happen. The deep learning technology is called Survival Study of Cardiac Arrhythmia Risk (SSCAR). The name alludes to cardiac scarring caused by heart disease that often results in lethal arrhythmias, and is the key to the algorithm’s predictions. The team used contrast-enhanced cardiac images that visualise scar distribution from hundreds of real patients at Johns Hopkins Hospital with cardiac scarring to train an algorithm to detect patterns and relationships not visible to the naked eye. Current clinical cardiac image analysis extracts only simple scar features like volume and mass, severely underutilising what’s demonstrated in this work to be critical data. ‘The images carry critical information that doctors haven’t been able to access,’ said first author Dan Popescu, a former Johns Hopkins doctoral student. ‘This scarring can be distributed in different ways and it says something about a patient’s chance for survival. There is information hidden in it.’ The team trained a second neural network to learn from 10 years of standard clinical patient data, 22 factors such as patients’ age, weight, race and prescription drug use. The algorithms’ predictions were not only significantly more accurate on every measure than doctors, they were validated in tests with an independent patient cohort from 60 health centres across the United States, with different cardiac histories and different imaging data, suggesting the platform could be adopted anywhere. ‘This has the potential to significantly shape clinical decision-making regarding arrhythmia risk and represents an essential step towards bringing patient trajectory prognostication into the age of artificial intelligence,’ said Trayanova, co-director of the Alliance for Cardiovascular Diagnostic and Treatment Innovation. ‘It epitomises the trend of merging artificial intelligence, engineering, and medicine as the future of healthcare.’ The team is now working to build algorithms to detect other cardiac diseases. According to Trayanova, the deeplearning concept could be developed for other fields of medicine that rely on visual diagnosis. Source: MedicalBrief 2022
RkJQdWJsaXNoZXIy NDIzNzc=